Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-04-05
1995-08-15
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540500, C07D21162, A61K 3800
Patent
active
054419522
ABSTRACT:
Fibrinogen receptor antagonists of the ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets, for example ##STR2##
REFERENCES:
patent: 4122255 (1980-10-01), Krapcho
patent: 4243807 (1981-01-01), Frieb et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
patent: 4622331 (1986-11-01), Jozie
patent: 5030654 (1991-07-01), Barnish
CA 74: 22903 (Schmidt), German Offen 1923821 70/11/19, 1970.)
Claremon David A.
Liverton Nigel
Kilby Scalzo Catherine S.
Merck & Co. , Inc.
Parr Richard S.
Richter Johann
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181916